Little Green Pharma Income Statement

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Jun '21 Jun 30, 2021
Operating Revenue	38.49	36.82	25.63	19.86	14.04	7
Other Revenue	-	0.02	1.49	-	-	-
Revenue	38.49	36.84	27.12	19.86	14.04	7
Revenue Growth (YoY)	26.76%	35.85%	36.55%	41.45%	100.47%	217.77%
Cost of Revenue	10.92	11.9	6.22	6.06	6.69	1.23
Gross Profit	27.57	24.94	20.9	13.8	7.35	5.78
Selling, General & Admin	21.89	22.04	22.37	19.52	25.66	8.21
Research & Development	0.08	0.29	0.58	1.47	4.06	-1.6
Other Operating Expenses	0	0.01	0.07	-	-	-
Operating Expenses	28.05	28.47	28.35	20.98	29.72	6.61
Operating Income	-0.47	-3.53	-7.45	-7.18	-22.37	-0.83
Interest Expense	-0.32	-0.29	-0.58	-0.93	-0.72	-0.09
Interest & Investment Income	0.04	0.02	0.17	0.05	0.04	0.04
Currency Exchange Gain (Loss)	-0.07	-0.05	0.01	-0.56	-1.35	-0.01
Other Non Operating Income (Expenses)	-0.09	-0.09	-0.06	0.06	0.33	0.52
EBT Excluding Unusual Items	-0.91	-3.95	-7.91	-8.56	-24.07	-0.38
Asset Writedown	-1.35	-0.85	-0.24	-	-	-
Other Unusual Items	-	-	-	-	-	22.59
Pretax Income	-2.26	-4.79	-8.15	-8.56	-24.07	22.22
Income Tax Expense	-8.12	-8.12	-	-	-	-
Earnings From Continuing Operations	5.86	3.32	-8.15	-8.56	-24.07	22.22
Earnings From Discontinued Operations	-	-	-	-0.65	-0.31	-
Net Income	5.86	3.32	-8.15	-9.21	-24.38	22.22
Net Income to Common	5.86	3.32	-8.15	-9.21	-24.38	22.22
Shares Outstanding (Basic)	304	302	300	250	236	154
Shares Outstanding (Diluted)	304	302	300	250	236	166
Shares Change (YoY)	0.95%	0.93%	19.91%	5.90%	42.33%	29.56%
EPS (Basic)	0.02	0.01	-0.03	-0.04	-0.10	0.14
EPS (Diluted)	0.02	0.01	-0.03	-0.04	-0.10	0.13
Free Cash Flow	-1.91	-1.15	-0.65	-8.76	-33.07	-6.05
Free Cash Flow Per Share	-0.01	-0.00	-0.00	-0.04	-0.14	-0.04
Gross Margin	71.63%	67.70%	77.07%	69.50%	52.38%	82.47%
Operating Margin	-1.23%	-9.59%	-27.48%	-36.17%	-159.33%	-11.90%
Profit Margin	15.21%	9.02%	-30.06%	-46.35%	-173.66%	317.20%
Free Cash Flow Margin	-4.95%	-3.13%	-2.39%	-44.10%	-235.51%	-86.36%
EBITDA	2.64	-0.28	-4.57	-4.35	-21.06	-0.35
EBITDA Margin	6.86%	-0.76%	-16.87%	-21.90%	-150.01%	-5.01%
D&A For EBITDA	3.11	3.25	2.88	2.83	1.31	0.48
EBIT	-0.47	-3.53	-7.45	-7.18	-22.37	-0.83
EBIT Margin	-1.23%	-9.59%	-27.48%	-36.17%	-159.33%	-11.90%
Revenue as Reported	-	-	-	-	14.04	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.